The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Calcitonin Injection Market Research Report 2025
Synopsis
The global Calcitonin Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Calcitonin injection is a medication used to treat bone diseases such as osteoporosis, Paget's disease, and hypercalcemia. It works by slowing down the breakdown of bone and increasing bone density. This can help prevent bone fractures and reduce bone pain.
Calcitonin is a natural hormone produced by the thyroid gland. The injectable form of calcitonin is derived from the salmon fish and is available as a prescription medication.
The injection is typically given by a healthcare professional and may be administered daily or several times a week, depending on the individual's condition and response to treatment.
Common side effects of calcitonin injection may include nausea, vomiting, diarrhea, and skin flushing. In some cases, allergic reactions and injection site reactions may occur.
It is important to discuss the potential risks and benefits of calcitonin injection with a healthcare provider before starting treatment. Additionally, patients should inform their healthcare provider of any other medications or supplements they are taking, as they may interact with calcitonin. Regular monitoring and follow-up appointments may be necessary to ensure the medication is effective and well-tolerated.
This report aims to provide a comprehensive presentation of the global market for Calcitonin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcitonin Injection.
Report Scope
The Calcitonin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Calcitonin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calcitonin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei Pharma
Future Health Pharma
Lisapharma
Novartis
Yingu
DAPHAE
Guoda Bio
Qingdao Guoda
Shanghai No.1 Bio
Guilin Pharma
Hybio Pharmaceutical
Chengdu List Pharma
CSPC
Segment by Type
Elcatonin Injection
Salmon Calcitonin Injection
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Calcitonin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Calcitonin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Calcitonin Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Calcitonin injection is a medication used to treat bone diseases such as osteoporosis, Paget's disease, and hypercalcemia. It works by slowing down the breakdown of bone and increasing bone density. This can help prevent bone fractures and reduce bone pain.
Calcitonin is a natural hormone produced by the thyroid gland. The injectable form of calcitonin is derived from the salmon fish and is available as a prescription medication.
The injection is typically given by a healthcare professional and may be administered daily or several times a week, depending on the individual's condition and response to treatment.
Common side effects of calcitonin injection may include nausea, vomiting, diarrhea, and skin flushing. In some cases, allergic reactions and injection site reactions may occur.
It is important to discuss the potential risks and benefits of calcitonin injection with a healthcare provider before starting treatment. Additionally, patients should inform their healthcare provider of any other medications or supplements they are taking, as they may interact with calcitonin. Regular monitoring and follow-up appointments may be necessary to ensure the medication is effective and well-tolerated.
This report aims to provide a comprehensive presentation of the global market for Calcitonin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcitonin Injection.
Report Scope
The Calcitonin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Calcitonin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calcitonin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei Pharma
Future Health Pharma
Lisapharma
Novartis
Yingu
DAPHAE
Guoda Bio
Qingdao Guoda
Shanghai No.1 Bio
Guilin Pharma
Hybio Pharmaceutical
Chengdu List Pharma
CSPC
Segment by Type
Elcatonin Injection
Salmon Calcitonin Injection
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Calcitonin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Calcitonin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Calcitonin Injection Market Overview
1.1 Product Overview and Scope of Calcitonin Injection
1.2 Calcitonin Injection Segment by Type
1.2.1 Global Calcitonin Injection Market Value Comparison by Type (2024-2030)
1.2.2 Elcatonin Injection
1.2.3 Salmon Calcitonin Injection
1.3 Calcitonin Injection Segment by Application
1.3.1 Global Calcitonin Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Calcitonin Injection Market Size Estimates and Forecasts
1.4.1 Global Calcitonin Injection Revenue 2019-2030
1.4.2 Global Calcitonin Injection Sales 2019-2030
1.4.3 Global Calcitonin Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Calcitonin Injection Market Competition by Manufacturers
2.1 Global Calcitonin Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Calcitonin Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Calcitonin Injection Average Price by Manufacturers (2019-2024)
2.4 Global Calcitonin Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Calcitonin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Calcitonin Injection, Product Type & Application
2.7 Calcitonin Injection Market Competitive Situation and Trends
2.7.1 Calcitonin Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Calcitonin Injection Players Market Share by Revenue
2.7.3 Global Calcitonin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Calcitonin Injection Retrospective Market Scenario by Region
3.1 Global Calcitonin Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Calcitonin Injection Global Calcitonin Injection Sales by Region: 2019-2030
3.2.1 Global Calcitonin Injection Sales by Region: 2019-2024
3.2.2 Global Calcitonin Injection Sales by Region: 2025-2030
3.3 Global Calcitonin Injection Global Calcitonin Injection Revenue by Region: 2019-2030
3.3.1 Global Calcitonin Injection Revenue by Region: 2019-2024
3.3.2 Global Calcitonin Injection Revenue by Region: 2025-2030
3.4 North America Calcitonin Injection Market Facts & Figures by Country
3.4.1 North America Calcitonin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Calcitonin Injection Sales by Country (2019-2030)
3.4.3 North America Calcitonin Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Calcitonin Injection Market Facts & Figures by Country
3.5.1 Europe Calcitonin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Calcitonin Injection Sales by Country (2019-2030)
3.5.3 Europe Calcitonin Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Calcitonin Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Calcitonin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Calcitonin Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Calcitonin Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Calcitonin Injection Market Facts & Figures by Country
3.7.1 Latin America Calcitonin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Calcitonin Injection Sales by Country (2019-2030)
3.7.3 Latin America Calcitonin Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Calcitonin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Calcitonin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Calcitonin Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Calcitonin Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Calcitonin Injection Sales by Type (2019-2030)
4.1.1 Global Calcitonin Injection Sales by Type (2019-2024)
4.1.2 Global Calcitonin Injection Sales by Type (2025-2030)
4.1.3 Global Calcitonin Injection Sales Market Share by Type (2019-2030)
4.2 Global Calcitonin Injection Revenue by Type (2019-2030)
4.2.1 Global Calcitonin Injection Revenue by Type (2019-2024)
4.2.2 Global Calcitonin Injection Revenue by Type (2025-2030)
4.2.3 Global Calcitonin Injection Revenue Market Share by Type (2019-2030)
4.3 Global Calcitonin Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Calcitonin Injection Sales by Application (2019-2030)
5.1.1 Global Calcitonin Injection Sales by Application (2019-2024)
5.1.2 Global Calcitonin Injection Sales by Application (2025-2030)
5.1.3 Global Calcitonin Injection Sales Market Share by Application (2019-2030)
5.2 Global Calcitonin Injection Revenue by Application (2019-2030)
5.2.1 Global Calcitonin Injection Revenue by Application (2019-2024)
5.2.2 Global Calcitonin Injection Revenue by Application (2025-2030)
5.2.3 Global Calcitonin Injection Revenue Market Share by Application (2019-2030)
5.3 Global Calcitonin Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Asahi Kasei Pharma
6.1.1 Asahi Kasei Pharma Corporation Information
6.1.2 Asahi Kasei Pharma Description and Business Overview
6.1.3 Asahi Kasei Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Asahi Kasei Pharma Calcitonin Injection Product Portfolio
6.1.5 Asahi Kasei Pharma Recent Developments/Updates
6.2 Future Health Pharma
6.2.1 Future Health Pharma Corporation Information
6.2.2 Future Health Pharma Description and Business Overview
6.2.3 Future Health Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Future Health Pharma Calcitonin Injection Product Portfolio
6.2.5 Future Health Pharma Recent Developments/Updates
6.3 Lisapharma
6.3.1 Lisapharma Corporation Information
6.3.2 Lisapharma Description and Business Overview
6.3.3 Lisapharma Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lisapharma Calcitonin Injection Product Portfolio
6.3.5 Lisapharma Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Calcitonin Injection Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Yingu
6.5.1 Yingu Corporation Information
6.5.2 Yingu Description and Business Overview
6.5.3 Yingu Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Yingu Calcitonin Injection Product Portfolio
6.5.5 Yingu Recent Developments/Updates
6.6 DAPHAE
6.6.1 DAPHAE Corporation Information
6.6.2 DAPHAE Description and Business Overview
6.6.3 DAPHAE Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 DAPHAE Calcitonin Injection Product Portfolio
6.6.5 DAPHAE Recent Developments/Updates
6.7 Guoda Bio
6.6.1 Guoda Bio Corporation Information
6.6.2 Guoda Bio Description and Business Overview
6.6.3 Guoda Bio Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guoda Bio Calcitonin Injection Product Portfolio
6.7.5 Guoda Bio Recent Developments/Updates
6.8 Qingdao Guoda
6.8.1 Qingdao Guoda Corporation Information
6.8.2 Qingdao Guoda Description and Business Overview
6.8.3 Qingdao Guoda Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qingdao Guoda Calcitonin Injection Product Portfolio
6.8.5 Qingdao Guoda Recent Developments/Updates
6.9 Shanghai No.1 Bio
6.9.1 Shanghai No.1 Bio Corporation Information
6.9.2 Shanghai No.1 Bio Description and Business Overview
6.9.3 Shanghai No.1 Bio Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai No.1 Bio Calcitonin Injection Product Portfolio
6.9.5 Shanghai No.1 Bio Recent Developments/Updates
6.10 Guilin Pharma
6.10.1 Guilin Pharma Corporation Information
6.10.2 Guilin Pharma Description and Business Overview
6.10.3 Guilin Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Guilin Pharma Calcitonin Injection Product Portfolio
6.10.5 Guilin Pharma Recent Developments/Updates
6.11 Hybio Pharmaceutical
6.11.1 Hybio Pharmaceutical Corporation Information
6.11.2 Hybio Pharmaceutical Calcitonin Injection Description and Business Overview
6.11.3 Hybio Pharmaceutical Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hybio Pharmaceutical Calcitonin Injection Product Portfolio
6.11.5 Hybio Pharmaceutical Recent Developments/Updates
6.12 Chengdu List Pharma
6.12.1 Chengdu List Pharma Corporation Information
6.12.2 Chengdu List Pharma Calcitonin Injection Description and Business Overview
6.12.3 Chengdu List Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Chengdu List Pharma Calcitonin Injection Product Portfolio
6.12.5 Chengdu List Pharma Recent Developments/Updates
6.13 CSPC
6.13.1 CSPC Corporation Information
6.13.2 CSPC Calcitonin Injection Description and Business Overview
6.13.3 CSPC Calcitonin Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CSPC Calcitonin Injection Product Portfolio
6.13.5 CSPC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Calcitonin Injection Industry Chain Analysis
7.2 Calcitonin Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Calcitonin Injection Production Mode & Process
7.4 Calcitonin Injection Sales and Marketing
7.4.1 Calcitonin Injection Sales Channels
7.4.2 Calcitonin Injection Distributors
7.5 Calcitonin Injection Customers
8 Calcitonin Injection Market Dynamics
8.1 Calcitonin Injection Industry Trends
8.2 Calcitonin Injection Market Drivers
8.3 Calcitonin Injection Market Challenges
8.4 Calcitonin Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
